Development of multiple myeloma after 15 years of treatment for polycythemia vera and successful treatment using bortezomib: A case report

Hideo Kimura; Miki Furukawa; Hirotaka Mori; Yutaka Shiga; Jun Asai; Keiji Satoh; Tatsuyuki Kai

doi:10.1002/ccr3.6614

Development of multiple myeloma after 15 years of treatment for polycythemia vera and successful treatment using bortezomib: A case report

Clin Case Rep. 2022 Nov 19;10(11):e6614. doi: 10.1002/ccr3.6614. eCollection 2022 Nov.

Authors

Hideo Kimura¹, Miki Furukawa¹, Hirotaka Mori¹, Yutaka Shiga¹, Jun Asai², Keiji Satoh², Tatsuyuki Kai¹

Affiliations

¹ Division of Hematology Kita-Fukushima Medical Center Date Japan.
² Division of Nephrology Fujita General Hospital Date Japan.

Abstract

Multiple myeloma (MM) and polycythemia vera (PV) rarely coexist; the clinical manifestations and treatment of this coexistence have not been described. An 81-year-old woman developed MM 15 years after undergoing PV treatment and was successfully treated using bortezomib. Herein, we share our experience of treating MM under such unusual conditions.

Keywords: bortezomib; multiple myeloma; myeloproliferative neoplasia; polycythemia vera.

Publication types

Case Reports